Melnyk: Crash chaos led to misreported financials

Biovail founder Eugene Melnyk took the stand for the first time Monday to say that "pandemonium" followed the 2003 truck accident that damaged a key Wellbutrin XL shipment. The aftermath was so chaotic, Melnyk said, that there wasn't time to sort out the wreck's exact financial impact. The reporting of that financial impact is central to Canadian securities regulators' allegations against the former drugs executive. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.